Jan 29, 2019 | By Thomas

Medtech company DePuy Synthes Ireland has announced that the company is investing €36 million in 3D printing research and development and creating 30 jobs at its Cork facility.

DePuy Synthes, which was acquired by Johnson & Johnson in 1998, is a global leader in orthopaedic and neurological solutions including hip and knee replacement joints. DePuy Synthes
employs more than 1,000 people at its innovation centre in Ringaskiddy, Co Cork.

As part of the new five year R&D project, the investment expands the scale and scope of activities taking place at the DePuy Synthes Innovation Centre. Projects will focus on advancing material science in 3D printing, coatings and surface treatments to meet future needs. The expansion includes the establishment of a 3D Printing Development and Launch Center on-site, in addition to the J&J 3D Bioprinting Laboratory, which launched last year in collaboration with Trinity College Dublin.

Gary Clerkin, Global Leader, Manufacturing Engineering, Science & Technology, DePuy Synthes, said: "This new programme will build on the dedication, hard work and excellent results delivered by the Innovation Centre over the past 10 years. It is crucial that we continue to deliver impactful research outcomes, and this advanced Materials and Surface Technology Centre will help accelerate innovation through the supply chain and shape the products of the future."

The five year project is supported by the Department of Business, Enterprise & Innovation, through IDA Ireland.



Posted in 3D Printer Company



Maybe you also like:


Leave a comment:

Your Name:


Subscribe us to

3ders.org Feeds 3ders.org twitter 3ders.org facebook   

About 3Ders.org

3Ders.org provides the latest news about 3D printing technology and 3D printers. We are now seven years old and have around 1.5 million unique visitors per month.

News Archive